TB-500
$74.99
In stockTB-500 is a commercial research name used for thymosin beta-4-related peptide materials studied in actin dynamics, cell migration, angiogenesis, and tissue-repair models.
| SKU | RC-ST-TB500-10MG |
|---|---|
| Manufacturer | Strandix Peptides |
| Form | Lyophilized Powder |
| Strength | 10 mg |
| Size | 3 mL Vial |
| Reported Result | See matching batch report |
| Stock | In stock |
| Documentation Status | Client-supplied report available |
Product Description
TTB-500 is an investigational synthetic peptide related to thymosin beta-4, a naturally occurring protein involved in cellular movement and tissue-repair biology. Published research commonly identifies TB-500 as Ac-LKKTETQ, an acetylated seven-amino-acid fragment corresponding to part of thymosin beta-4’s actin-binding region.
Interest in TB-500 centers on whether this fragment can influence processes associated with wound repair.
What research has shown:
Repair-related activity from a related fragment: Studies using unacetylated LKKTETQ reported improved wound healing in laboratory and animal models.
Metabolite-specific laboratory findings: A study examining TB-500 and its breakdown products found significant wound-healing activity in a fibroblast assay only for one tested metabolite, Ac-LKKTE.
Storage and handling: Keep sealed lyophilized material protected from moisture and light at the manufacturer-specified temperature. Require COA confirmation of exact amino-acid sequence, molecular mass, assay, purity, counterion, water content, and sterility/endotoxin status where claimed.
Third-party testing status.
| Batch / Lot | Reported Result | Tested | Partner | Status | Document |
|---|---|---|---|---|---|
| TB10/2025-12-18-B | 99.538%; 99.542% | Dec 31, 2025 | Janoshik | Client-supplied report | View COA |
.png)